Serotonin receptor expression in hippocampus and temporal cortex of temporal lobe epilepsy patients by postictal generalized electroencephalographic suppression duration.


Journal

Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R

Informations de publication

Date de publication:
11 2022
Historique:
revised: 18 08 2022
received: 28 06 2022
accepted: 18 08 2022
pubmed: 3 9 2022
medline: 15 11 2022
entrez: 2 9 2022
Statut: ppublish

Résumé

Prolonged postictal generalized electroencephalographic suppression (PGES) is a potential biomarker for sudden unexpected death in epilepsy (SUDEP), which may be associated with dysfunctional autonomic responses and serotonin signaling. To better understand molecular mechanisms, PGES duration was correlated to 5HT1A and 5HT2A receptor protein expression and RNAseq from resected hippocampus and temporal cortex of temporal lobe epilepsy patients with seizures recorded in preoperative evaluation. Analyses included 36 cases (age = 14-64 years, age at epilepsy onset = 0-51 years, epilepsy duration = 2-53 years, PGES duration = 0-93 s), with 13 cases in all hippocampal analyses. 5HT1A and 5HT2A protein was evaluated by Western blot and histologically in hippocampus (n = 16) and temporal cortex (n = 9). We correlated PGES duration to our previous RNAseq dataset for serotonin receptor expression and signaling pathways, as well as weighted gene correlation network analysis (WGCNA) to identify correlated gene clusters. In hippocampus, 5HT2A protein by Western blot positively correlated with PGES duration (p = .0024, R Higher hippocampal 5HT2A receptor protein and potassium channel transcripts may reflect underlying mechanisms contributing to or resulting from prolonged PGES. Future studies with larger cohorts should assess functional analyses and additional brain regions to elucidate mechanisms underlying PGES and SUDEP risk.

Identifiants

pubmed: 36053862
doi: 10.1111/epi.17400
pmc: PMC9669210
mid: NIHMS1837134
doi:

Substances chimiques

Serotonin 333DO1RDJY
Receptors, Serotonin 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2925-2936

Subventions

Organisme : NIA NIH HHS
ID : P30 AG066512
Pays : United States
Organisme : NIMH NIH HHS
ID : R25 MH086466
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS090415
Pays : United States

Informations de copyright

© 2022 International League Against Epilepsy.

Références

PLoS One. 2022 May 19;17(5):e0268597
pubmed: 35587487
Cold Spring Harb Perspect Med. 2016 May 02;6(5):
pubmed: 27141079
Epilepsy Res. 2007 Jun;75(1):39-45
pubmed: 17485199
Epilepsy Behav. 2011 Jul;21(3):271-4
pubmed: 21570920
Curr Opin Neurol. 2021 Apr 1;34(2):206-212
pubmed: 33664206
J Clin Neurophysiol. 2015 Feb;32(1):14-20
pubmed: 25647769
Lancet Neurol. 2013 Oct;12(10):966-77
pubmed: 24012372
Front Mol Neurosci. 2018 Jul 30;11:258
pubmed: 30104956
Front Aging Neurosci. 2016 Jul 05;8:163
pubmed: 27458372
Brain Pathol. 2022 Sep;32(5):e13074
pubmed: 35478467
Neuropharmacology. 2009 Jan;56(1):273-84
pubmed: 18761359
J Transl Med. 2021 Oct 21;19(1):440
pubmed: 34674725
IEEE Trans Biomed Eng. 2018 Feb;65(2):371-377
pubmed: 29346105
J Nucl Med. 2012 Sep;53(9):1375-82
pubmed: 22782314
Front Mol Neurosci. 2019 Sep 20;12:224
pubmed: 31616248
Exp Neurol. 2020 Mar;325:113145
pubmed: 31866464
Adv Neurol. 1999;79:311-21
pubmed: 10514823
PLoS Med. 2008 Jan 22;5(1):e8
pubmed: 18215105
Neuroscience. 2021 Jan 15;453:206-221
pubmed: 33242541
Neurobiol Dis. 2018 Feb;110:47-58
pubmed: 29141182
Epilepsy Res. 2010 Feb;88(2-3):183-8
pubmed: 20018491
J Neurosci. 2004 Jan 14;24(2):412-9
pubmed: 14724239
Neurology. 2013 Oct 1;81(14):1252-6
pubmed: 23966251
J Steroid Biochem Mol Biol. 2016 Jan;155(Pt A):112-9
pubmed: 26466768
J Steroid Biochem Mol Biol. 2017 Jul;171:288-295
pubmed: 28457967
Brain Res Bull. 2000 Apr;51(6):499-505
pubmed: 10758340
J Neurosci. 2020 Jun 17;40(25):4936-4944
pubmed: 32414785
Neuroscientist. 2018 Aug;24(4):368-380
pubmed: 29542386
Brain Commun. 2022 Jul 12;4(4):fcac186
pubmed: 35928051
Epilepsia. 2018 Jun;59(6):e91-e97
pubmed: 29771456
Auton Neurosci. 2021 Nov;235:102862
pubmed: 34411885
Science. 2008 Jul 4;321(5885):130-3
pubmed: 18599790
Seizure. 2017 May;48:28-32
pubmed: 28380395
J Neurochem. 2003 Jun;85(5):1087-100
pubmed: 12753068
Seizure. 2017 Jan;44:11-20
pubmed: 28007376
Neurology. 2013 Apr 16;80(16):1465-71
pubmed: 23516322
Ann Neurol. 2010 Dec;68(6):787-96
pubmed: 20882604
Brain Commun. 2021 Jul 09;3(3):fcab149
pubmed: 34396109
Front Pharmacol. 2015 Mar 17;6:46
pubmed: 25852551
Neurobiol Dis. 2016 Aug;92(Pt A):18-45
pubmed: 26299390
Epilepsy Res. 2021 Nov;177:106777
pubmed: 34601387
J Nucl Med. 2005 Jul;46(7):1128-35
pubmed: 16000281
Neurobiol Dis. 2020 Feb;134:104612
pubmed: 31533065
Cell Syst. 2017 Jan 25;4(1):60-72.e4
pubmed: 27989508
Neurology. 2021 May 25;96(21):e2639-e2652
pubmed: 33910938
J Neurochem. 2007 Feb;100(4):857-73
pubmed: 17212700

Auteurs

Dominique Frances Leitner (DF)

Comprehensive Epilepsy Center, New York University Grossman School of Medicine, New York, New York, USA.
Center for Cognitive Neurology, New York University Grossman School of Medicine, New York, New York, USA.
Department of Neurology, New York University Grossman School of Medicine, New York, New York, USA.

Sasha Devore (S)

Comprehensive Epilepsy Center, New York University Grossman School of Medicine, New York, New York, USA.
Department of Neurology, New York University Grossman School of Medicine, New York, New York, USA.

Juliana Laze (J)

Comprehensive Epilepsy Center, New York University Grossman School of Medicine, New York, New York, USA.
Department of Neurology, New York University Grossman School of Medicine, New York, New York, USA.

Daniel Friedman (D)

Comprehensive Epilepsy Center, New York University Grossman School of Medicine, New York, New York, USA.
Department of Neurology, New York University Grossman School of Medicine, New York, New York, USA.

James D Mills (JD)

Department of (Neuro)pathology, Amsterdam Neuroscience, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Department of Clinical and Experimental Epilepsy, University College London Institute of Neurology, London, UK.
Chalfont Centre for Epilepsy, Bucks, UK.

Yan Liu (Y)

Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, New York, USA.

Michael Janitz (M)

School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, New South Wales, Australia.

Jasper J Anink (JJ)

Department of (Neuro)pathology, Amsterdam Neuroscience, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Johannes C Baayen (JC)

Department of Neurosurgery, Amsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam Free University, Amsterdam, The Netherlands.

Sander Idema (S)

Department of Neurosurgery, Amsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam Free University, Amsterdam, The Netherlands.

Erwin Alexander van Vliet (EA)

Department of (Neuro)pathology, Amsterdam Neuroscience, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Center for Neuroscience, Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands.

Beate Diehl (B)

Department of Clinical and Experimental Epilepsy, University College London Institute of Neurology, London, UK.

Catherine Scott (C)

Department of Clinical and Experimental Epilepsy, University College London Institute of Neurology, London, UK.

Roland Thijs (R)

Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands.

Maromi Nei (M)

Department of Neurology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Manor Askenazi (M)

Biomedical Hosting, Arlington, Massachusetts, USA.
Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, New York, USA.

Shobi Sivathamboo (S)

Department of Neuroscience, Alfred Health, Central Clinical School, Melbourne, Victoria, Australia.
Department Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.

Terence O'Brien (T)

Department of Neuroscience, Alfred Health, Central Clinical School, Melbourne, Victoria, Australia.
Department Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.

Thomas Wisniewski (T)

Center for Cognitive Neurology, New York University Grossman School of Medicine, New York, New York, USA.
Department of Neurology, New York University Grossman School of Medicine, New York, New York, USA.
Department of Pathology, New York University Grossman School of Medicine, New York, New York, USA.
Department of Psychiatry, New York University Grossman School of Medicine, New York, New York, USA.

Maria Thom (M)

Department of Clinical and Experimental Epilepsy, University College London Institute of Neurology, London, UK.

Eleonora Aronica (E)

Department of (Neuro)pathology, Amsterdam Neuroscience, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands.

Maura Boldrini (M)

Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, New York, USA.
Columbia University Irving Medical Center, Department of Psychiatry, New York, New York, USA.

Orrin Devinsky (O)

Comprehensive Epilepsy Center, New York University Grossman School of Medicine, New York, New York, USA.
Department of Neurology, New York University Grossman School of Medicine, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH